7-year-old Eva is a cheerful and strong girl. She loves going to school, singing, and drawing, and her biggest dream is to walk one day.

When Eva was just 6 months old, she was diagnosed with spinal muscular atrophy (SMA), a severe genetic disease that gradually weakens the muscles and can lead to serious motor, respiratory, and other complications.

For Eva, continuous treatment with Evrysdi (Risdiplam) is vital. Thanks to your support, we were previously able to provide her with a one-year supply of the medication, helping preserve her functional abilities and prevent her condition from worsening.

This time, the Health Fund for Children of Armenia has managed to obtain the medication from the official supplier at a price almost three times lower. One month of Eva’s medication costs $4,820, and $19,280 is needed to cover the next 4 months.

Interrupting the treatment is highly undesirable, while importing the medication takes time. Eva’s family knows the risks of the disease progressing especially well: one of her older brothers also has SMA and today is unable to move independently.

Let us help Eva continue the treatment she needs without interruption, preserve her abilities, and move closer to her biggest dream: being able to walk.